DJIA 17,005.49 -34.00 -0.20%
NASDAQ 4,539.80 7.70 0.17%
S&P 500 1,988.38 -3.99 -0.20%
market minute promo

0.91 0.01 (1.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMUC $0.91 1.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.90
Previous Close $0.90
Daily Range $0.90 - $0.93
52-Week Range $0.65 - $4.00
Market Cap $55.2M
P/E Ratio -6.00
Dividend (Yield) $0.00 (0.0%)
Volume 253,540
Average Daily Volume 397,394
Current FY EPS -$0.24

Sector

Healthcare

Industry

Healthcare Information Services

ImmunoCellular Therapeutics, Ltd. (IMUC) Description

ImmunoCellular Therapeutics, Ltd. Website: http://www.imuc.com/

News & Commentary

3 Possible Catalysts for Inovio Pharmaceuticals in 2014

Inovio Pharmaceuticals could be a stock to watch in 2014 for these three reasons.

5 Companies Developing New Cancer Drugs

ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q2 2014 Results - Earnings Call Transcript

Wednesday Sector Laggards: Drugs, Biotechnology Stocks

Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer

Positive Trends For ImmunoCellular Therapeutics

Twelve Analyst Stocks to Buy Under $10 With Huge Implied Upside

Monday Sector Laggards: Drugs, Manufacturing Stocks

ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis P

ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO

Sector Update: Healthcare Shares Flat Pre-Market; ImmunoCelluar up 12% on Positive Data on Immunothe

Sector Update: Healthcare Shares Flat Pre-Market; ImmunoCelluar up 12% on Positive Data on Immunotherapeutic Vaccine

5 Stocks Poised for Breakouts

See More IMUC News...

IMUC's Top Competitors

IMUC $0.91 (1.11%)
Current stock: IMUC
JNJ $103.09 (-0.39%)
Current stock: JNJ
NVS $88.95 (0.00%)
Current stock: NVS
RHHBY $36.36 (-0.22%)
Current stock: RHHBY